Validation and comparison of tumor-associated trypsin inhibitor (TATI) immunoassays.
Janeiro E, Guimarães J, Stenman UH, Catarino M, Itkonen O
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of patient age and gender, fasting prior to collection, collection tube type, storage, freeze-thaw cycling, and quantification platform on TATI concentrations in serum and the effects of collecting lithium-heparin plasma instead of serum on TATI levels. To determine the effect of long-term storage, TATI levels in 152 specimens stored at -70 degrees C for 9-11 years were compared to levels in 15 fresh specimens. For the freeze-thaw experiment no details of storage duration or thaw temperature or duration were included.
Summary of Findings
TATI levels were significantly lower in specimens from women aged 31-50 years than those from 18-30 year old women (p=0.0115). In both men and women, TATI was higher serum from individuals over 70 years old than in serum from 51-70 year old patients (p=0.0005 and p=0.0001, respectively). Serum TATI levels were higher in specimens from 18-30 year old women than those from men of the same age (p<0.0001), but no other gender differences were observed. Fasting prior to blood draw, collecting lithium-heparin plasma rather than serum, and serum tube type had no effects on TATI concentrations. The authors report that when serum was stored for 4 weeks at 4 or 20 degrees C, TATI concentrations decreased from initial levels by 15.9% and 19.9%, respectively, but the authors did not note any differences observed at other timepoints. Similarly, the authors report that after 8 weeks at -80 degrees C, TATI concentrations decreased by 19% from initial levels, but they do not discuss other timepoints. Further, the authors report a 19.2% decline in TATI levels after serum was subjected to 4 freeze-thaw cycles at -20 degrees C. Specimens stored for 9-11 years at -70 degrees C had a mean TATI concentration that was 18% lower than the mean level in fresh specimens. The median TATI concentrations were 11.0, 13.5, and 16.0 ug/L using the RIA, IFMA and ELISA, respectively (p<0.0001, all). The intra-assay CVs using ELISA and IFMA were 7.1% and 9.7%, respectively, at 9.5 ug/L and 9.1% and 3.5%, respectively, at 18.8 ug/L. Further, recovery of TATI from spiked serum was less than 87.7-98.7% using IFMA, but 100-117% using ELISA.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
None (Fresh)FrozenDiagnoses
NormalPlatforms
ProteinELISAProteinRadioimmunoassayProteinImmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Patient age 18-30 years31-50 years51-70 years>70 yearsPreaquisition Patient gender FemaleMaleBiospecimen Acquisition Time of biospecimen collection After Finish breakfastBefore eatingBiospecimen Acquisition Type of collection container/solution Clotting catalyzator tubeGlass tubeLithium-heparin tubeSST II advance tubeBiospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Storage duration 0 days1 week2 weeks4 weeks8 weeks9-11 yearsStorage Storage temperature -20 degrees C-70 degrees C-80 degrees C4 degrees CImmunoassay Specific Technology platform ELISARIATR-IFMA